Skip to main content
logo
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
68.39
-3.99 (-5.51%)
Sep 15, 2026, 4:00 PM EDT - Market closed

BridgeBio Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
13,37014,7405,1867,0231,1392,455
Market Cap Growth
36.57%184.24%-26.16%516.57%-53.61%-71.83%
Enterprise Value
16,02316,8016,6618,2292,2713,264
Last Close Price
68.3976.4927.4440.377.6216.68

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.7529.3623.37754.9214.6735.22
PB Ratio
--7.10-3.56-5.23-0.91-2.84

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
22.4733.4630.02884.5129.2546.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.35-0.90-1.19-1.30-1.38-1.99
Net Debt / Equity Ratio
-1.06-0.61-0.72-0.97-1.00-1.03
Net Debt / EBITDA Ratio
-5.61-2.57-1.84-2.20-2.71-1.57
Net Debt / FCF Ratio
-6.09-2.85-2.01-2.47-2.95-1.74
Asset Turnover
0.620.540.300.020.100.08
Quick Ratio
1.092.524.443.044.036.34
Current Ratio
1.232.774.673.324.526.58
Return on Assets (ROA)
-26.00%-33.83%-49.24%-64.08%-35.80%-41.75%
Return on Capital Employed (ROCE)
-146.30%-77.50%-75.50%-148.90%-93.40%-65.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.17%-4.92%-10.33%-9.16%-42.24%-22.91%
FCF Yield
-3.26%-3.03%-10.06%-7.53%-37.25%-20.82%
Buyback Yield / Dilution
-2.29%-2.93%-14.30%-10.39%-2.16%-22.34%
SEC Filings: 10-K · 10-Q